Modernizing Pharmaceutical Governance and Medicines Supply Systems

Ascend Systems for Health is a Ghana- and U.S.-registered advisory firm supporting governments and development partners to strengthen regulatory oversight, institutional management systems, and supply chain governance. We integrate sustainable local ownership and responsible AI-enabled decision support to advance equitable access to, and appropriate use of quality-assured medicines.
Equitable Access. Appropriate Use. Stronger Systems.
Explore Our Services

Advisory services for governments, donors, and development partners

WHY ASCEND SYSTEMS FOR HEALTH

Our work spans the entire pharmaceutical value chain, from regulation and supply to prescribing, dispensing, and patient use, because access without appropriate use does not improve health outcomes.

Country-Led by Design
We work within national systems, not parallel to them, supporting governments in leading, owning, and sustaining reforms.
Systems, Not Silos
Our approach integrates regulation, supply chains, workforce, and digital governance across the full pharmaceutical value chain.
Technology With Purpose
We apply AI and digital tools pragmatically to improve decision-making and efficiency measurably.
Built for the New Global Health Reality
We support governments to build resilient, sustainable systems as external support evolves, and work with governments and donors to manage orderly transitions.
OUR CORE OFFERINGS
Pharmaceutical Regulatory & Stewardship Systems
Strengthening regulatory architecture, risk-based inspection, compliance intelligence, and stewardship frameworks to ensure medicines and health products are safe, effective, and appropriately governed.
Medicines Supply Chain Governance & Performance
Strengthening governance, oversight, and performance management systems so essential medicines move reliably, efficiently, and transparently across national supply chains.
Pharmaceutical Care, PV & Rational Use Governance
Advancing systems that promote responsible prescribing, pharmacovigilance, adherence monitoring, and quality pharmaceutical care within national regulatory and service delivery frameworks.
Institutional Governance & Workforce Systems
Strengthening organizational structures, management systems, and workforce oversight mechanisms that sustain pharmaceutical regulation, supply chain operations, and manufacturing readiness.
AI-Enabled Regulatory Intelligence & Oversight Modernization
Applying advanced analytics and AI-enabled decision support to modernize inspection prioritization, compliance monitoring, forecasting, and pharmaceutical system performance oversight.
Transition & Sustainability Advisory
Supporting structured transitions from donor-supported pharmaceutical systems to nationally governed, financially sustainable, and institutionally accountable models that safeguard service continuity and patient safety.
WHO WE ARE
Ascend Systems for Health is a systems-focused advisory firm that supports governments in strengthening pharmaceutical governance, supply chain systems, and oversight for sustainable outcomes.

We focus on regulation, governance, workforce capacity, and the appropriate use of medicines, strengthened through data-driven and AI-enabled decision support to improve system performance and patient-centered outcomes. Our work also advances antimicrobial stewardship and national readiness for local and regional pharmaceutical manufacturing.

Global Vision, Country-Led Expansion
Registered in Ghana and the United States, Ascend Systems for Health brings global expertise in regulation, supply chains, AI-enabled governance, and manufacturing readiness to support resilient national systems.
 
 

Institutional Experience

Ascend’s leadership and advisory network bring extensive experience supporting pharmaceutical systems reform across multiple low- and middle-income countries. Our experience spans regulatory modernization, institutional strengthening, supply chain governance, and performance-driven systems reform.

  • Experience across 30+ countries
  • Oversight of $450M+ in program portfolios managed or advised
  • Systems reforms influencing 100M+ population-level impact
  • Performance-driven delivery across complex health environments